Because levothyroxine requirements increase as early as the fifth week of gestationwhich is often before a first obstetric visitand because maternal hypothyroidism can lead to fetal cognitive deficits and even death, women with hypothyroidism may need to increase their dose of levothyroxine by about 30% as soon as pregnancy is confirmed.
The recommendation comes from a prospective study involving 19 women and 17 full-term births. The researchers found that a mean increase of 47% in levothyroxine dose was required in 17 of 20 pregnancies (85%) to maintain thyrotropin concentrations at prepregnancy values. The increase was required within the first half of the pregnancies, often by 8 weeks' gestation, and remained necessary until delivery.
The increase in thyrotropin occurred whether or not the women had a history of thyroid cancer. Women who became pregnant by means of assisted reproductive technologies had even greater increases in thyrotropin early in gestation than those who conceived spontaneously. They also had significantly higher concentrations of serum estradiol at 7 weeks' gestation. Increased estradiol is what many experts believe is at the core of why extra levothyroxine is required. Estradiol causes an increase in serum concentrations of thyroxine-binding globulin, which, in turn, decreases the thyroid hormone-binding ratio.
The necessary increase in levothyroxine translates into about two daily doses per week. The author of an editorial in the same issue of the Journal posits that increasing the dose by 25 to 50 µg daily and requesting thyroid-function testing within the following 4 to 6 weeks makes practical sense. The author also suggests that the findings of the latest study support the need to measure serum thyroxine, thyrotropin, or both, in all women of childbearing age to detect unrecognized thyroid failure before pregnancy occurs.
Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351:241-249.
Toft A. Increased levothyroxine requirements in pregnancyWhy, when, and how much? N Engl J Med. 2004;351:292-294.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More